Here is what you need to know on Thursday, February 4:
US Treasury yields continue their upward march amid hopes for a large US stimulus package, carrying the dollar higher and commodities lower. The effect of vaccine news and upbeat US data is fading ahead of the BOE's rate decision and US jobless claims.
Stimulus: Democrats have taken another step to pass President Joe Biden's $1.9 trillion coronavirus relief package via a fast track. Talks with moderates from both parties continue and the final program could be lower. Prospects of higher debt issuance and a booming economy have been prompting a sell-off in bonds, raising their yields.
Elevated returns on US government debt have pushed the dollar higher, with EUR/USD nearing 1.20 and GBP/USD dipping under 1.36. Gold has been on the back foot, nearing $1,800.
The American economy is doing well according to the latest figures. ADP's jobs report showed a robust increase in jobs while the ISM Services Purchasing Managers' Index exceeded estimates as well. Both serve as hints toward Friday's Nonfarm Payrolls figures. Weekly jobless claims are set to drop for a third consecutive week.
US stock markets are relatively stable after a few days of rallies. Treasury Secretary Janet Yellen will meet regulators to discuss the frenzy around the "Reddit stocks" such as GameStop. See Gamestop (GME) fades the rebound as SEC digs into social media fraud
The Bank of England is set to leave its policy unchanged and publish its Monetary Policy Report on "Super Thursday." Governor Andrew Bailey will likely comment on the BOE's review of negative interest rates, the outlook for the economy and Britain's successful vaccination campaign. The UK inoculated 10 million of its citizens.
The EU is set to receive immunization doses from AstraZeneca over the weekend, allowing it to reignite its vaccination campaign. Mario Draghi, the former President of the European Central Bank, was given the mandate to try to form a new government.
Data coming from Israel, the world's leader in the field, show a significant drop in hospitalizations and severe disease among the over 60s, who were prioritized with the jabs.
Cryptocurrencies have been extending their gains above $38,000 and Ehtereum topping $1,600. Dogecoin is also of high interest.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.